Analysis of transcription profiling of 1904 breast cancer patients on METABRIC data set suggests that overexpression of Atox1 may serve as a marker for breast cancer prognosis [25] but only in the hormone receptor-positive tumors. Here, ATOX1 is linked to breast carcinoma.